Court Reconfirms Judgment in IGEN Suit Against Roche
go back to news archives IGEN International, Inc. (Nasdaq: IGEN) announced today that the U.S. District Court for the District of Maryland reaffirmed its final order of judgment in IGEN's case against Roche Diagnostics, a division of F. Hoffmann-La Roche (OTC Bulletin Board: RHHBY). The judgment, which was entered on February 15, 2002, awards IGEN $505 million in damages; confirms the Company's right to terminate the license agreement; and directs and commands Roche to grant to IGEN for use in its retained fields a license to improvements developed by Roche under the agreement, including Roche's Elecsys(R) diagnostics product line.
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : IGEN International, Inc. View archived contact details
Posted on April 15, 2002
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
LIMS Launchpad Series: Episode #1 - Strategic Planning
17 Jul 2025 -
Navigating Nitrosamine Challenges: From Risk Assessment to Enhanced Ames Testing and Analytics
21 Jul 2025 -
IAFP 2025
27 Jul 2025 -
ADLM 2025
27 Jul 2025 -
Food Safety Culture Workshop
9 Sep 2025 -
Who are the "Real" Spoilers in Food?
11 Sep 2025 -
CPD accredited course: Level 3 HACCP & Food Safety
15 Sep 2025 -
Culture Eats HACCP for Breakfast (free)
On-demand Webinar -
A3P International Congress 2025
7 Oct 2025 -
Microbiology Method Evaluation and Verification
16 Oct 2025